Site search
2861 results for '' found
A Phase 2 Randomized, Double Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Barzolvolimab (CDX-0159) in Adults with Active Eosinophilic Esophagitis (The EvolvE Study) (NCT05
A Phase 2 Randomized, Double Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Barzolvolimab (CDX-0159) in Adults with Active Eosinophilic Esophagitis (The EvolvE Study) (NCT05
/
Ultra-Early, minimally inVAsive intraCerebral haemorrhage evacUATion versus standard trEatment (EVACUATE) (NCT04434807)
Ultra-Early, minimally inVAsive intraCerebral haemorrhage evacUATion versus standard trEatment (EVACUATE) (NCT04434807)
/
A double-blinded randomised placebo-controlled trial of estradiol: investigating the effect on disordered eating symptoms of women with anorexia nervosa (ACTRN12623000897662)
A double-blinded randomised placebo-controlled trial of estradiol: investigating the effect on disordered eating symptoms of women with anorexia nervosa (ACTRN12623000897662)
/
A randomised placebo controlled trial of estradiol for the treatment of women with borderline personality disorder. (ACTRN12617001317381)
A randomised placebo controlled trial of estradiol for the treatment of women with borderline personality disorder. (ACTRN12617001317381)
/
A Phase I, Open-Label, Multi-Center Dose Finding Study to Investigate the Safety, Pharmacokinetics, and Preliminary Efficacy of ATG-017 Monotherapy or Combination Therapy with Nivolumab in Patien
A Phase I, Open-Label, Multi-Center Dose Finding Study to Investigate the Safety, Pharmacokinetics, and Preliminary Efficacy of ATG-017 Monotherapy or Combination Therapy with Nivolumab in Patien
/
A randomized, open-label Phase III study in patients with previously treated unresectable or metastatic NRAS mutant cutaneous melanoma comparing the combination of naporafenib + trametinib to phy
A randomized, open-label Phase III study in patients with previously treated unresectable or metastatic NRAS mutant cutaneous melanoma comparing the combination of naporafenib + trametinib to phy
/
A randomised, double-blind, placebo-controlled trial of erythropoietin alfa versus placebo in machnically ventilated critically ill patients following traumatic injury. (ACTRN12619001632189)
A randomised, double-blind, placebo-controlled trial of erythropoietin alfa versus placebo in machnically ventilated critically ill patients following traumatic injury. (ACTRN12619001632189)
/
A prospective study to assess the safety of a sub-scalp monitoring device for the recording of brain electrical activity associated with the occurrence of epileptic seizures (ACTRN12619001587190)
A prospective study to assess the safety of a sub-scalp monitoring device for the recording of brain electrical activity associated with the occurrence of epileptic seizures (ACTRN12619001587190)
/
A Phase II Open-Label, Multi-Centre Study of Minimal Residual Disease-Directed Consolidation with Epcoritamab or Epcoritamab-Lenalidomide-Rituximab Post Anti-CD19 CAR T-Cell Therapy for Large B-C
A Phase II Open-Label, Multi-Centre Study of Minimal Residual Disease-Directed Consolidation with Epcoritamab or Epcoritamab-Lenalidomide-Rituximab Post Anti-CD19 CAR T-Cell Therapy for Large B-C
/
Effect of cannabidiol on sleep in developmental and epileptic encephalopathies (ACTRN12623000855628p)
Effect of cannabidiol on sleep in developmental and epileptic encephalopathies (ACTRN12623000855628p)
/